To determine whether acute measurements of peripheral markers improve prediction of ischemic stroke outcome in humans and also whether the level of these markers at the onset of stroke will be associated with hemorrhagic transformation.
Biomarker samples will be drawn at baseline, 4 hours (if in project 1), and 48 hours. The subjects will also have information collected on their neurological status, diet, medical history, medications, and stroke subtype at specific time points in the study.
|Type||Measure||Time Frame||Safety Issue|
|No outcomes associated with this trial.|